RDH5与RLBP1相关遗传性视网膜疾病:细化静止型与进展型表型谱
回顾性单中心队列研究纳入22例RLBP1相关视网膜病变和5例RDH5相关视网膜病变患者,分析临床、功能与影像特征。RLBP1基因型黄斑体积较RDH5低0.28 mm3,两基因型均见显著年黄斑体积丢失率,3例RLBP1 c.361C>T纯合患者表现轻微视杆视锥功能损害且无黄斑萎缩。
要点
- RDH5相关视网膜病变成人患者可发现进展性黄斑萎缩合并先天性夜盲。
- RLBP1基因型黄斑体积较RDH5基因型低0.28 mm3(95%CI -0.46至-0.11,P=.005)。
- 两基因型年黄斑体积丢失率-0.007 mm3/y(95%CI -0.012至-0.001,P=.02),无显著差异。
核心结论
- RDH5相关视网膜病变成人患者可识别出先天性夜盲之外的进展性黄斑萎缩,而RLBP1低效变异可导致较轻视网膜表型而非典型严重视杆视锥营养不良伴黄斑萎缩。
研究设计与样本
- 回顾性单中心队列研究,纳入22例分子确诊RLBP1相关视网膜病变患者和5例RDH5相关视网膜病变患者,复习病历获取家族史和眼科检查资料,包括视网膜影像和全视野视网膜电图(ffERG),基因型通过靶向二代测序确定并经Sanger测序确认及家系分离验证。
主要发现
- RDH5和RLBP1队列基线年龄中位数(四分位距)分别为44.6(38.2-67.9)岁和36.9(23.1-45.2)岁;两队列约80%患眼发现黄斑萎缩(MA);RLBP1基因型黄斑体积较RDH5基因型低0.28 mm3(95%CI -0.46至-0.11;P=.005);两基因型队列均发现显著年黄斑体积丢失率-0.007 mm3/y(95%CI -0.012至-0.001;P=.02),两基因型间无显著差异;3例无亲缘关系RLBP1 c.361C>T p.(Arg121Trp)纯合患者ffERG显示视杆和视锥系统功能轻微损害且无黄斑萎缩。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the clinical, functional, and imaging characteristics in patients affected by inherited retinal diseases associated with RDH5 and RLBP1 gene variants, and to report novel genotype-phenotype correlations. DESIGN: Retrospective single-center cohort study. METHODS: Twenty-two patients with molecularly confirmed RLBP1-associated retinopathy and 5 with RDH5-associated retinopathy. Medical records were reviewed to obtain data on family history and ophthalmologic examinations, including retinal imaging and full-field electroretinography (ffERG). Genotype was determined by targeted next-generation sequencing followed by confirmation and familial segregation by Sanger sequencing. RESULTS: The median (interquartile ranges) age at baseline for the RDH5 and RLBP1 cohort was 44.6 (38.2-67.9) years and 36.9 (23.1-45.2) years, respectively. Macular atrophy (MA) was found in approximately 80% of eyes from both cohorts. The RLBP1 genotype was associated with a lower macular volume by 0.28 mm3 (95% CI, -0.46 to -0.11; P = .005) compared to the RDH5 genotype. In both genotypic cohorts, we found a significant annual rate of macular volume loss, estimated at -0.007 mm3/y (95% CI, -0.012 to -0.001; P = .02), without any significant difference between the two genotypes. Three unrelated patients homozygous for the c.361C>T p.(Arg121Trp) RLBP1 variant showed minimal impairment of both the rod and cone systems function on ffERG and absence of MA. CONCLUSIONS: Progressive MA in addition to congenital night blindness can be identified in adult patients with RDH5-associated retinopathy. Vice versa, hypomorphic RLBP1 variants may cause milder retinal phenotypes rather than the typical severe rod-cone dystrophy with MA. These findings could prove beneficial to improve the prognostication of patients and help in designing future interventional trials.
引用
- Bianco L, Antropoli A, Benadji A, et al. RDH5 and RLBP1-Associated Inherited Retinal Diseases: Refining the Spectrum of Stationary and Progressive Phenotypes. Am J Ophthalmol. 2024. PMID: 38945349. doi:10.1016/j.ajo.2024.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。